IT News<p>More bad news for psychedelic drug company: FDA expands probe after rejection - Enlarge / President of Multidisciplinary Association for Psychedelic S... - <a href="https://arstechnica.com/?p=2045406" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://</span><span class="">arstechnica.com/?p=2045406</span><span class="invisible"></span></a> <a href="https://schleuss.online/tags/psychedelics" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>psychedelics</span></a> <a href="https://schleuss.online/tags/science" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>science</span></a> <a href="https://schleuss.online/tags/health" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>health</span></a> <a href="https://schleuss.online/tags/lykos" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>lykos</span></a> <a href="https://schleuss.online/tags/maps" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>maps</span></a> <a href="https://schleuss.online/tags/mdma" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>mdma</span></a> <a href="https://schleuss.online/tags/ptsd" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ptsd</span></a></p>